Jay Bhattacharya, 18th NIH Director, shared a post on X:

“The National Institutes of Health remains absolutely committed to the health and welfare of our clinical trial participants, so many of whom over the years have been successfully treated and helped advance medical knowledge by orders of magnitude.

I find it deeply disappointing of Dr. Rosenberg to claim staffing issues are delaying his research, especially in light of the funding alternatives that were presented to him, which he has been slow in pursuing.

As to the current re-organization, no clinical trial has been delayed, nor has any participant been dropped from any clinical trial. These are the facts. NIH clinical trial participants and the American people need to know them.”

More posts featuring Jay Bhattacharya.

Jay Bhattacharya Responds to Criticism on NIH Clinical Trial Reorganization

“The National Institutes of Health remains absolutely committed to the health and welfare of our clinical trial participants, so many of whom over the years have been successfully treated and helped advance medical knowledge by orders of magnitude.

I find it deeply disappointing of Dr. Rosenberg to claim staffing issues are delaying his research, especially in light of the funding alternatives that were presented to him, which he has been slow in pursuing.

As to the current re-organization, no clinical trial has been delayed, nor has any participant been dropped from any clinical trial. These are the facts. NIH clinical trial participants and the American people need to know them.”